| 1 |
30692503 | [A Case of Resistance to Systemic Therapy in Hypermutation of Colorectal Cancer]. | 2018 Dec |
1 |
| 2 |
28624221 | miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2. | 2017 Jun 16 |
2 |
| 3 |
28101205 | Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation. | 2016 Dec |
2 |
| 4 |
25996601 | Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer. | 2015 |
4 |
| 5 |
23420099 | Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin. | 2013 Feb |
2 |
| 6 |
20930505 | Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner. | 2010 Dec 1 |
1 |
| 7 |
21078976 | MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). | 2010 Dec 7 |
2 |
| 8 |
15611052 | DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. | 2005 Feb 18 |
1 |